{"id":"https://openalex.org/W4396496945","doi":"https://doi.org/10.2174/0118744710284298240419115911","title":"Radiopharmaceuticals Adverse Events Management","display_name":"Radiopharmaceuticals Adverse Events Management","publication_year":2024,"publication_date":"2024-04-30","ids":{"openalex":"https://openalex.org/W4396496945","doi":"https://doi.org/10.2174/0118744710284298240419115911","pmid":"https://pubmed.ncbi.nlm.nih.gov/38685803"},"language":"en","primary_location":{"id":"doi:10.2174/0118744710284298240419115911","doi":"https://doi.org/10.2174/0118744710284298240419115911","is_oa":false,"landing_page_url":"https://doi.org/10.2174/0118744710284298240419115911","pdf_url":null,"source":{"id":"https://openalex.org/S80350757","display_name":"Current Radiopharmaceuticals","issn_l":"1874-4710","issn":["1874-4710","1874-4729"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-1","ki-jl-1","norway-1","poland-40","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Radiopharmaceuticals","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5005327474","display_name":"Ana Agudo Mart\u00ednez","orcid":"https://orcid.org/0009-0001-1796-8400","observed_orcids":["https://orcid.org/0009-0001-1796-8400"]},"institutions":[{"id":"https://openalex.org/I4210090436","display_name":"Hospital Universitario Virgen Macarena","ror":"https://ror.org/016p83279","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210090436"]}],"countries":["ES"],"is_corresponding":true,"raw_author_name":"Ana Agudo Mart\u00ednez","raw_affiliation_strings":["Department of Nuclear Medicine, Virgen Macarena University Hospital, Seville, Spain"],"raw_orcid":"https://orcid.org/0009-0001-1796-8400","affiliations":[{"raw_affiliation_string":"Department of Nuclear Medicine, Virgen Macarena University Hospital, Seville, Spain","institution_ids":["https://openalex.org/I4210090436"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091343158","display_name":"Gertrudis Sabatel Hern\u00e1ndez","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210090436","display_name":"Hospital Universitario Virgen Macarena","ror":"https://ror.org/016p83279","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210090436"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Gertrudis Sabatel Hernandez","raw_affiliation_strings":["Department of Nuclear Medicine, Virgen Macarena University Hospital, Seville, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Nuclear Medicine, Virgen Macarena University Hospital, Seville, Spain","institution_ids":["https://openalex.org/I4210090436"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014112190","display_name":"Manuela Molina Mora","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210090436","display_name":"Hospital Universitario Virgen Macarena","ror":"https://ror.org/016p83279","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210090436"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Manuela Molina Mora","raw_affiliation_strings":["Department of Nuclear Medicine, Virgen Macarena University Hospital, Seville, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Nuclear Medicine, Virgen Macarena University Hospital, Seville, Spain","institution_ids":["https://openalex.org/I4210090436"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069467683","display_name":"Pablo Antonio de la Riva-P\u00e9rez","orcid":"https://orcid.org/0000-0002-5093-5782","observed_orcids":["https://orcid.org/0000-0002-5093-5782"]},"institutions":[{"id":"https://openalex.org/I4210090436","display_name":"Hospital Universitario Virgen Macarena","ror":"https://ror.org/016p83279","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210090436"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Pablo Antonio de la Riva Perez","raw_affiliation_strings":["Department of Nuclear Medicine, Virgen Macarena University Hospital, Seville, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Nuclear Medicine, Virgen Macarena University Hospital, Seville, Spain","institution_ids":["https://openalex.org/I4210090436"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113193121","display_name":"Rosa Fernandez Lopez","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210090436","display_name":"Hospital Universitario Virgen Macarena","ror":"https://ror.org/016p83279","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210090436"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Rosa Fernandez Lopez","raw_affiliation_strings":["Department of Nuclear Medicine, Virgen Macarena University Hospital, Seville, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Nuclear Medicine, Virgen Macarena University Hospital, Seville, Spain","institution_ids":["https://openalex.org/I4210090436"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031633199","display_name":"T. Cambil Molina","orcid":"https://orcid.org/0000-0002-5440-9763","observed_orcids":["https://orcid.org/0000-0002-5440-9763"]},"institutions":[{"id":"https://openalex.org/I4210090436","display_name":"Hospital Universitario Virgen Macarena","ror":"https://ror.org/016p83279","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210090436"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Teresa Cambil Molina","raw_affiliation_strings":["Department of Nuclear Medicine, Virgen Macarena University Hospital, Seville, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Nuclear Medicine, Virgen Macarena University Hospital, Seville, Spain","institution_ids":["https://openalex.org/I4210090436"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5044327602","display_name":"Cinta Calvo Mor\u00f3n","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210090436","display_name":"Hospital Universitario Virgen Macarena","ror":"https://ror.org/016p83279","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210090436"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Cinta Calvo Moron","raw_affiliation_strings":["Department of Nuclear Medicine, Virgen Macarena University Hospital, Seville, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Nuclear Medicine, Virgen Macarena University Hospital, Seville, Spain","institution_ids":["https://openalex.org/I4210090436"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5005327474"],"corresponding_institution_ids":["https://openalex.org/I4210090436"],"apc_list":null,"apc_paid":null,"fwci":1.4713,"has_fulltext":false,"cited_by_count":6,"citation_normalized_percentile":{"value":0.76598805,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":98},"biblio":{"volume":"18","issue":"1","first_page":"45","last_page":"55"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.7339000105857849,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.7339000105857849,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11395","display_name":"Radiopharmaceutical Chemistry and Applications","score":0.19840000569820404,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11894","display_name":"Radiology practices and education","score":0.029100000858306885,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/radiopharmaceuticals","display_name":"radiopharmaceuticals","score":0.9950000047683716},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.949999988079071},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.8429999947547913},{"id":"https://openalex.org/keywords/drug-drug-interactions","display_name":"drug-drug interactions","score":0.8080000281333923},{"id":"https://openalex.org/keywords/adverse-event-reporting","display_name":"adverse event reporting","score":0.9369999766349792},{"id":"https://openalex.org/keywords/radiopharmacists","display_name":"radiopharmacists","score":0.7540000081062317},{"id":"https://openalex.org/keywords/patient-safety","display_name":"patient safety","score":0.9259999990463257},{"id":"https://openalex.org/keywords/management-guidelines","display_name":"management guidelines","score":0.5440000295639038},{"id":"https://openalex.org/keywords/nuclear-medicine","display_name":"nuclear medicine","score":0.6890000104904175}],"concepts":[{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.8458496928215027},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7174615859985352},{"id":"https://openalex.org/C2778715236","wikidata":"https://www.wikidata.org/wiki/Q55622662","display_name":"Discontinuation","level":2,"score":0.5612457990646362},{"id":"https://openalex.org/C2780182762","wikidata":"https://www.wikidata.org/wiki/Q1630279","display_name":"Guideline","level":2,"score":0.5030462145805359},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.4823895990848541},{"id":"https://openalex.org/C2993432071","wikidata":"https://www.wikidata.org/wiki/Q45959","display_name":"Drug reaction","level":3,"score":0.4304659962654114},{"id":"https://openalex.org/C57658597","wikidata":"https://www.wikidata.org/wiki/Q1550789","display_name":"Pharmacovigilance","level":3,"score":0.4168752431869507},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.3658024072647095},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.27748847007751465},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.1671936810016632},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.13916656374931335}],"mesh":[{"descriptor_ui":"D004347","descriptor_name":"Drug Interactions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016907","descriptor_name":"Adverse Drug Reaction Reporting Systems","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D019275","descriptor_name":"Radiopharmaceuticals","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D064420","descriptor_name":"Drug-Related Side Effects and Adverse Reactions","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.2174/0118744710284298240419115911","doi":"https://doi.org/10.2174/0118744710284298240419115911","is_oa":false,"landing_page_url":"https://doi.org/10.2174/0118744710284298240419115911","pdf_url":null,"source":{"id":"https://openalex.org/S80350757","display_name":"Current Radiopharmaceuticals","issn_l":"1874-4710","issn":["1874-4710","1874-4729"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-1","ki-jl-1","norway-1","poland-40","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Radiopharmaceuticals","raw_type":"journal-article"},{"id":"pmid:38685803","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/38685803","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current radiopharmaceuticals","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9391000270843506,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1944538987","https://openalex.org/W2117209639","https://openalex.org/W7220782968","https://openalex.org/W3094482189","https://openalex.org/W2733814880","https://openalex.org/W7100006867","https://openalex.org/W2117820330","https://openalex.org/W2305120344","https://openalex.org/W1177611524","https://openalex.org/W4409209721"],"abstract_inverted_index":{"BACKGROUND":[0],"AND":[1],"PURPOSE:":[2],"Radiopharmaceuticals":[3],"are":[4,14,44],"radioactive":[5],"compounds":[6],"used":[7,187],"for":[8,76,112,178,193,201,224],"diagnostic":[9,40],"or":[10],"therapeutic":[11],"purposes":[12],"which":[13],"most":[15],"often":[16],"administered":[17],"intravenously.":[18],"Adverse":[19,42],"events":[20,82,215],"that":[21],"may":[22],"induce":[23],"both":[24],"adverse":[25,81,105,131,147,160,197,214,248],"reactions":[26,43,161,198,249],"and":[27,39,52,119,149,172,199,227,242,245],"drug-to-drug":[28],"interactions":[29,207,239],"with":[30,115,124,208,217],"changes":[31],"in":[32,71,85,169],"expected":[33],"biodistribution,":[34],"potentially":[35],"affecting":[36],"patient":[37,252],"safety":[38],"accuracy.":[41],"relatively":[45],"rare":[46],"due":[47],"to":[48,63,69,73,103,188,205,250],"the":[49,55,67,77,127,154,170,194,222],"small":[50],"doses":[51],"under-reporting":[53],"is":[54,62,219],"norm.":[56],"The":[57,108,182,211],"aim":[58],"of":[59,66,79,129,136,144,196,203,213,237],"this":[60],"study":[61],"increase":[64],"awareness":[65,236],"need":[68,223],"report":[70,123],"order":[72],"create":[74],"protocols":[75],"management":[78,128,195,229],"such":[80],"among":[83],"professionals":[84],"a":[86,96,164,190],"Nuclear":[87],"Medicine":[88],"Department.":[89],"METHODS:":[90],"A":[91,134],"reporting":[92,156,226,233],"system":[93,234],"was":[94,176],"established":[95],"decade":[97],"ago":[98],"through":[99],"an":[100,121],"electronic":[101],"form":[102],"enhance":[104,251],"event":[106],"registration.":[107],"radiopharmacist":[109],"collects":[110],"data":[111],"further":[113],"communication":[114],"National":[116],"Health":[117],"authorities":[118],"develops":[120],"annual":[122,183],"recommendations":[125,200],"on":[126],"these":[130],"events.":[132],"RESULTS:":[133],"total":[135],"128":[137],"reports":[138,184],"were":[139],"collected,":[140],"including":[141],"65":[142],"cases":[143],"extravasations,":[145],"18":[146],"reactions,":[148],"45":[150],"drug":[151,180],"interactions.":[152],"Over":[153],"years,":[155],"has":[157],"been":[158,186],"increasing,":[159,220],"occurred":[162],"at":[163],"higher":[165],"incidence":[166],"than":[167],"reported":[168],"literature,":[171],"each":[173],"anomalous":[174],"biodistribution":[175],"analysed":[177],"possible":[179,238],"interaction.":[181],"have":[185],"develop":[189],"local":[191],"guideline":[192],"discontinuation":[202],"treatment":[204],"avoid":[206],"radiopharmaceuticals.":[209],"CONCLUSION:":[210],"recognition":[212],"associated":[216],"radiopharmaceuticals":[218,241],"underlining":[221],"vigilant":[225],"improved":[228],"strategies.":[230],"An":[231],"efficient":[232],"promotes":[235],"between":[240],"other":[243],"medicines":[244],"their":[246],"potential":[247],"safety.":[253]},"counts_by_year":[{"year":2026,"cited_by_count":5},{"year":2025,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2024-05-01T00:00:00"}